[
  {
    "ts": null,
    "headline": "Agilent Technologies Inc. stock outperforms competitors on strong trading day",
    "summary": "Agilent Technologies Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=e2d527e170321a57b0194386cb58b9bcc4112a655531af71bb932fd1d5f11c90",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757955360,
      "headline": "Agilent Technologies Inc. stock outperforms competitors on strong trading day",
      "id": 136810523,
      "image": "",
      "related": "A",
      "source": "MarketWatch",
      "summary": "Agilent Technologies Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=e2d527e170321a57b0194386cb58b9bcc4112a655531af71bb932fd1d5f11c90"
    }
  },
  {
    "ts": null,
    "headline": "Is Agilent's Raised 2025 Outlook and Surprising Demand Shift Reshaping the Investment Case for Agilent (A)?",
    "summary": "Agilent Technologies recently reported fiscal Q3 2025 earnings and revenue that came in above analyst expectations, leading the company to raise its full-year revenue guidance to between US$6.91 billion and US$6.93 billion while tightening its EPS outlook. This update indicates improving demand for Agilent's laboratory research and drug development tools, underlining management's confidence in expanding core markets. We'll explore how Agilent's updated financial guidance and renewed demand...",
    "url": "https://finnhub.io/api/news?id=cd957a3aa852e9d1f66950f4f13a0327c2634d450009990c364198dc67a353d1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757936608,
      "headline": "Is Agilent's Raised 2025 Outlook and Surprising Demand Shift Reshaping the Investment Case for Agilent (A)?",
      "id": 136749826,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "A",
      "source": "Yahoo",
      "summary": "Agilent Technologies recently reported fiscal Q3 2025 earnings and revenue that came in above analyst expectations, leading the company to raise its full-year revenue guidance to between US$6.91 billion and US$6.93 billion while tightening its EPS outlook. This update indicates improving demand for Agilent's laboratory research and drug development tools, underlining management's confidence in expanding core markets. We'll explore how Agilent's updated financial guidance and renewed demand...",
      "url": "https://finnhub.io/api/news?id=cd957a3aa852e9d1f66950f4f13a0327c2634d450009990c364198dc67a353d1"
    }
  }
]